All Stories

  1. Olfaction, pain sensitivity and immunoendocrine system in substance use disorders
  2. PSYCHOMETRIC EVALUATION OF SYMPTOMS AND CLINICAL DYNAMICS OF SCHIZOPHRENIA IN DEPENDING ON CONSTITUTIONALLY-MORPHOLOGICAL TYPE OF THE PATIENTS
  3. Interferon gamma inducer in therapy of schizophrenia
  4. Association of Cytokine Production with Hormone Level and Sensory Responses during the Formation of Psychoactive Drug Addiction in Men
  5. P.1.f.004 Immunomodulating effects of classical and atypical antipsychotics
  6. 1585 – Social adaptation and immune reactivity in schizophrenia
  7. P03-264 - Dynamics of psychopathological symptomatology and cytokine levels in the process of schizophrenic patients treatment
  8. P.3.f.012 Psychoneuroimmune interactions in schizophrenia
  9. P03-84 - Immune reactivity and variants of clinical-social adaptation in schizophrenia
  10. TECHNOLOGY OF IMMUNOCORRECTION AT MENTAL DISORDERS
  11. P.3.d.01l The immunomodulatory effects of atypical neuroleptics quetiapine and amisulpride in the dynamics of 6-week treatment
  12. P.3.d.011 Immunotropic effects of atypical neuroleptics olanzapine and amisulpride
  13. Immune parameters and aminotransferase blood serum level in dynamics of atypical neuroleptics treatment of schizophrenic patients
  14. P.2.021 Effects of atypical neurolepticquetiapine on blood indices, humoral immunity and body weight in patients with schizophrenia
  15. P.2.016 Influence of atypical neuroleptic on cell apoptosis in patients with schizophrenia in the course of the therapy
  16. Stress and immunity by change of place of residence
  17. The basic variants of immune function in schizophrenia
  18. Ego defense mechanisms and immunological status